CY1111110T1 - Τετρακυκλικα στεροειδη παραγωγα χρησιμα ως διαμορφωτες υποδοχεα προγεστερονης - Google Patents

Τετρακυκλικα στεροειδη παραγωγα χρησιμα ως διαμορφωτες υποδοχεα προγεστερονης

Info

Publication number
CY1111110T1
CY1111110T1 CY20111100046T CY111100046T CY1111110T1 CY 1111110 T1 CY1111110 T1 CY 1111110T1 CY 20111100046 T CY20111100046 T CY 20111100046T CY 111100046 T CY111100046 T CY 111100046T CY 1111110 T1 CY1111110 T1 CY 1111110T1
Authority
CY
Cyprus
Prior art keywords
receptors
products useful
construction processor
steroid products
tetracyclic steroid
Prior art date
Application number
CY20111100046T
Other languages
English (en)
Inventor
Ningyi Chen
Nareshkumar F Jain
Zhihua Sui
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1111110T1 publication Critical patent/CY1111110T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε τετρακυκλικά στεροειδή παράγωγα, σε φαρμακευτικές συνθέσεις που περιέχουν αυτά, και στη χρησιμοποίηση τους στη θεραπευτική αγωγή διαταραχών και καταστάσεων που διαμορφώνονται από έναν υποδοχέα προγεστερόνης ή γλυκοκορτικοειδών.
CY20111100046T 2006-02-17 2011-01-14 Τετρακυκλικα στεροειδη παραγωγα χρησιμα ως διαμορφωτες υποδοχεα προγεστερονης CY1111110T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77434806P 2006-02-17 2006-02-17
EP07757092A EP1996571B1 (en) 2006-02-17 2007-02-16 Tetracyclic steroid derivatives useful as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
CY1111110T1 true CY1111110T1 (el) 2015-06-11

Family

ID=38290140

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100046T CY1111110T1 (el) 2006-02-17 2011-01-14 Τετρακυκλικα στεροειδη παραγωγα χρησιμα ως διαμορφωτες υποδοχεα προγεστερονης

Country Status (16)

Country Link
US (1) US7390831B2 (el)
EP (1) EP1996571B1 (el)
JP (1) JP5230451B2 (el)
CN (1) CN101421261B (el)
AT (1) ATE485286T1 (el)
AU (1) AU2007217097B2 (el)
CA (1) CA2642763A1 (el)
CY (1) CY1111110T1 (el)
DE (1) DE602007009945D1 (el)
DK (1) DK1996571T3 (el)
ES (1) ES2353133T3 (el)
HK (1) HK1126475A1 (el)
PL (1) PL1996571T3 (el)
PT (1) PT1996571E (el)
SI (1) SI1996571T1 (el)
WO (1) WO2007098384A2 (el)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2077752B1 (el) * 1970-02-11 1973-03-16 Roussel Uclaf

Also Published As

Publication number Publication date
HK1126475A1 (en) 2009-09-04
US20070197634A1 (en) 2007-08-23
AU2007217097A1 (en) 2007-08-30
CN101421261B (zh) 2013-01-23
CN101421261A (zh) 2009-04-29
SI1996571T1 (sl) 2011-02-28
US7390831B2 (en) 2008-06-24
AU2007217097B2 (en) 2012-12-06
PL1996571T3 (pl) 2011-04-29
EP1996571A2 (en) 2008-12-03
JP5230451B2 (ja) 2013-07-10
CA2642763A1 (en) 2007-08-30
EP1996571B1 (en) 2010-10-20
JP2009527492A (ja) 2009-07-30
DK1996571T3 (da) 2011-02-07
DE602007009945D1 (de) 2010-12-02
WO2007098384A2 (en) 2007-08-30
PT1996571E (pt) 2010-12-07
WO2007098384A3 (en) 2007-10-04
ATE485286T1 (de) 2010-11-15
ES2353133T3 (es) 2011-02-25

Similar Documents

Publication Publication Date Title
CY1111128T1 (el) Στεροειδη παραγωγα 17-φωσφορου χρησιμα ως τροποποιητες υποδοχεων προγεστερονης
ATE514700T1 (de) Neues tetrazyklisches heteroatom mit als sexualsteroidhormon-rezeptormodulatoren geeigneten derivaten
WO2010054158A3 (en) Steroid modulators of glucocorticoid receptor
CR10243A (es) "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos"
EA201370066A1 (ru) Модуляторы эстрогеновых рецепторов и их применение
CY1113146T1 (el) 11-φωσφο-στεροειδη παραγωγα ως τροποποιητες του υποδοχεα προγεστερονης
TW200626156A (en) Amido compounds and their use as pharmaceuticals
EA201270815A1 (ru) Модуляторы рецепторов эстрогена и их применение
WO2007038138A3 (en) Amido compounds and their use as pharmaceuticals
TW200621725A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
TW200624424A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
MX2019006877A (es) Derivados de 4-pregenen-11ss-17-21-triol-3,20-diona para el tratamiento de afecciones oculares.
EA201190236A1 (ru) Новые производные стероидных соединений [3,2-c]пиразолов с глюкокортикоидной активностью
ATE542795T1 (de) Benzylpiperazinderivate als motilin- rezeptorantagonisten
BR112012014235A2 (pt) tiazóis bicíclicos como moduladores alostéricos de receptores mglur5
ATE473741T1 (de) Neue imidazolopyrazolderivate als selektive androgen-rezeptor-modulatoren
ATE482195T1 (de) Benzoäfüisoindole als antagonisten des ep4- rezeptors
WO2008109719A3 (en) Steroids derivatives as selective progesterone receptor modulators
CY1111110T1 (el) Τετρακυκλικα στεροειδη παραγωγα χρησιμα ως διαμορφωτες υποδοχεα προγεστερονης
UA89043C2 (ru) Амидосоединения и их применение как фармацевтических средств
WO2009140225A3 (en) Anti-inflammatory and immunosuppresive glucocorticoid steroids
CY1113127T1 (el) Οξα στεροειδη παραγωγα ως εκλεκτικοι τροποποιητες υποδοχεων προγεστερονης
EP1883624A4 (en) D-HOMOANDROSTA-17-YL CARBAMATE DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR LIGANDS
SI1812417T1 (sl) Novi derivati 2H-kromena kot selektivni modulatorji estrogenskega receptorja
ATE540953T1 (de) Bizyklische imidazol- oder thiadiazol- heterozyklen als selektive androgen-rezeptor- modulatoren